DAPASUG-VM-500 TABS Tablet
MRP: 1,574
Packaging: 10x10
Pack Type: tablet
Composition:
DAPAGLIFLOZIN PROPANEDIOL MONOHYDRATE 10 mg VILDAGLIPTIN 100mg METFORMIN HYDROCHLORIDE IP 500mg (SR)
Indication:
Used to manage type 2 diabetes mellitus in adults when blood sugar is not controlled with dual therapy. It helps lower blood glucose by improving insulin action, increasing insulin release, and promoting glucose loss through urine. Ask ChatGPT
Description:
This advanced triple-combination antidiabetic formulation contains:
Dapagliflozin Propanediol Monohydrate 10 mg
Vildagliptin 100 mg
Metformin Hydrochloride IP 500 mg (Sustained Release)
It is specially designed for the effective management of Type 2 Diabetes Mellitus (T2DM) in adults whose blood glucose levels are not adequately controlled with monotherapy or dual therapy.
This combination works through three complementary mechanisms:
Dapagliflozin (SGLT2 inhibitor) reduces blood sugar by increasing urinary glucose excretion.
Vildagliptin (DPP-4 inhibitor) enhances incretin hormone activity, improving insulin secretion and reducing glucagon release.
Metformin SR decreases hepatic glucose production and improves insulin sensitivity while providing sustained glucose control with fewer gastrointestinal side effects.
The triple-action formula provides:
Better HbA1c reduction
Fasting and postprandial glucose control
Weight-neutral or modest weight reduction benefits
Lower risk of hypoglycemia compared to sulfonylureas
It is suitable for long-term glycemic control under medical supervision.
Tags:
- Helps reduce HbA1c effectively
- Controls fasting and post-meal blood glucose levels
- Improves insulin sensitivity
- Promotes urinary glucose elimination
- Lower risk of hypoglycemia
- Sustained release metformin ensures prolonged action
- Supports weight management in diabetic patients
Usage Information
Dosage
Take as prescribed by the physician. Usually taken once daily, preferably with food to reduce gastric discomfort. Swallow whole; do not crush or chew (due to SR formulation). Maintain adequate hydration while using dapagliflozin. Regular blood glucose monitoring is advised
Side Effects
Common: Nausea Diarrhea Urinary tract infections Genital fungal infections Headache Less Common but Serious: Lactic acidosis (rare, metformin-related) Ketoacidosis (rare) Hypoglycemia (when combined with insulin/sulfonylureas) Dehydration Seek medical attention if severe symptoms occur.
Contraindications
Type 1 diabetes mellitus Severe renal impairment Diabetic ketoacidosis Hypersensitivity to any component Severe hepatic impairment History of lactic acidosis Use cautiously in elderly patients and those with kidney disease.
Availability
Dapagliflozin 10 mg tablet, Vildagliptin 100 mg tablet, Metformin SR 500 mg, Triple combination antidiabetic, SGLT2 inhibitor with DPP4 inhibitor, Type 2 diabetes treatment, HbA1c control medicine, Oral antidiabetic tablets, Diabetes management therapy